Global Enterovirus Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
LPI (LP Information)' newest research report, the “Enterovirus Vaccine Industry Forecast” looks at past sales and reviews total world Enterovirus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Enterovirus Vaccine sales for 2023 through 2029. With Enterovirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enterovirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Enterovirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enterovirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enterovirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enterovirus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enterovirus Vaccine.
The global Enterovirus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Enterovirus Vaccine players cover Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Enterovirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Enterovirus Vaccine market?
What factors are driving Enterovirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enterovirus Vaccine market opportunities vary by end market size?
How does Enterovirus Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
LPI (LP Information)' newest research report, the “Enterovirus Vaccine Industry Forecast” looks at past sales and reviews total world Enterovirus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Enterovirus Vaccine sales for 2023 through 2029. With Enterovirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enterovirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Enterovirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enterovirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enterovirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enterovirus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enterovirus Vaccine.
The global Enterovirus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Enterovirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Enterovirus Vaccine players cover Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Enterovirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Coxasckievirus A
- Coxasckievirus B
- Human Enterovirus 71
- Others
- Hospital
- Research Institute
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sinovac Biotech
- Medigen Vaccine Biologics
- Shenzhen Neptunus
- Sinopharm
- Adimmune
- Intravacc
- Shanghai Zerun Biotechnology
- Beijing Minhai Biotechnology
What is the 10-year outlook for the global Enterovirus Vaccine market?
What factors are driving Enterovirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enterovirus Vaccine market opportunities vary by end market size?
How does Enterovirus Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enterovirus Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Enterovirus Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Enterovirus Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Enterovirus Vaccine Segment by Type
2.2.1 Coxasckievirus A
2.2.2 Coxasckievirus B
2.2.3 Human Enterovirus
2.2.4 Others
2.3 Enterovirus Vaccine Sales by Type
2.3.1 Global Enterovirus Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Enterovirus Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Enterovirus Vaccine Sale Price by Type (2018-2023)
2.4 Enterovirus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Others
2.5 Enterovirus Vaccine Sales by Application
2.5.1 Global Enterovirus Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Enterovirus Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Enterovirus Vaccine Sale Price by Application (2018-2023)
3 GLOBAL ENTEROVIRUS VACCINE BY COMPANY
3.1 Global Enterovirus Vaccine Breakdown Data by Company
3.1.1 Global Enterovirus Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Enterovirus Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Enterovirus Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Enterovirus Vaccine Revenue by Company (2018-2023)
3.2.2 Global Enterovirus Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Enterovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Enterovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enterovirus Vaccine Product Location Distribution
3.4.2 Players Enterovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENTEROVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Enterovirus Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Enterovirus Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Enterovirus Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Enterovirus Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Enterovirus Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Enterovirus Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Enterovirus Vaccine Sales Growth
4.4 APAC Enterovirus Vaccine Sales Growth
4.5 Europe Enterovirus Vaccine Sales Growth
4.6 Middle East & Africa Enterovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Enterovirus Vaccine Sales by Country
5.1.1 Americas Enterovirus Vaccine Sales by Country (2018-2023)
5.1.2 Americas Enterovirus Vaccine Revenue by Country (2018-2023)
5.2 Americas Enterovirus Vaccine Sales by Type
5.3 Americas Enterovirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enterovirus Vaccine Sales by Region
6.1.1 APAC Enterovirus Vaccine Sales by Region (2018-2023)
6.1.2 APAC Enterovirus Vaccine Revenue by Region (2018-2023)
6.2 APAC Enterovirus Vaccine Sales by Type
6.3 APAC Enterovirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enterovirus Vaccine by Country
7.1.1 Europe Enterovirus Vaccine Sales by Country (2018-2023)
7.1.2 Europe Enterovirus Vaccine Revenue by Country (2018-2023)
7.2 Europe Enterovirus Vaccine Sales by Type
7.3 Europe Enterovirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enterovirus Vaccine by Country
8.1.1 Middle East & Africa Enterovirus Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Enterovirus Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Enterovirus Vaccine Sales by Type
8.3 Middle East & Africa Enterovirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enterovirus Vaccine
10.3 Manufacturing Process Analysis of Enterovirus Vaccine
10.4 Industry Chain Structure of Enterovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enterovirus Vaccine Distributors
11.3 Enterovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ENTEROVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Enterovirus Vaccine Market Size Forecast by Region
12.1.1 Global Enterovirus Vaccine Forecast by Region (2024-2029)
12.1.2 Global Enterovirus Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enterovirus Vaccine Forecast by Type
12.7 Global Enterovirus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sinovac Biotech
13.1.1 Sinovac Biotech Company Information
13.1.2 Sinovac Biotech Enterovirus Vaccine Product Portfolios and Specifications
13.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sinovac Biotech Main Business Overview
13.1.5 Sinovac Biotech Latest Developments
13.2 Medigen Vaccine Biologics
13.2.1 Medigen Vaccine Biologics Company Information
13.2.2 Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolios and Specifications
13.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medigen Vaccine Biologics Main Business Overview
13.2.5 Medigen Vaccine Biologics Latest Developments
13.3 Shenzhen Neptunus
13.3.1 Shenzhen Neptunus Company Information
13.3.2 Shenzhen Neptunus Enterovirus Vaccine Product Portfolios and Specifications
13.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shenzhen Neptunus Main Business Overview
13.3.5 Shenzhen Neptunus Latest Developments
13.4 Sinopharm
13.4.1 Sinopharm Company Information
13.4.2 Sinopharm Enterovirus Vaccine Product Portfolios and Specifications
13.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinopharm Main Business Overview
13.4.5 Sinopharm Latest Developments
13.5 Adimmune
13.5.1 Adimmune Company Information
13.5.2 Adimmune Enterovirus Vaccine Product Portfolios and Specifications
13.5.3 Adimmune Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Adimmune Main Business Overview
13.5.5 Adimmune Latest Developments
13.6 Intravacc
13.6.1 Intravacc Company Information
13.6.2 Intravacc Enterovirus Vaccine Product Portfolios and Specifications
13.6.3 Intravacc Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Intravacc Main Business Overview
13.6.5 Intravacc Latest Developments
13.7 Shanghai Zerun Biotechnology
13.7.1 Shanghai Zerun Biotechnology Company Information
13.7.2 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
13.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shanghai Zerun Biotechnology Main Business Overview
13.7.5 Shanghai Zerun Biotechnology Latest Developments
13.8 Beijing Minhai Biotechnology
13.8.1 Beijing Minhai Biotechnology Company Information
13.8.2 Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
13.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Minhai Biotechnology Main Business Overview
13.8.5 Beijing Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enterovirus Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Enterovirus Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Enterovirus Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Enterovirus Vaccine Segment by Type
2.2.1 Coxasckievirus A
2.2.2 Coxasckievirus B
2.2.3 Human Enterovirus
2.2.4 Others
2.3 Enterovirus Vaccine Sales by Type
2.3.1 Global Enterovirus Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Enterovirus Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Enterovirus Vaccine Sale Price by Type (2018-2023)
2.4 Enterovirus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Others
2.5 Enterovirus Vaccine Sales by Application
2.5.1 Global Enterovirus Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Enterovirus Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Enterovirus Vaccine Sale Price by Application (2018-2023)
3 GLOBAL ENTEROVIRUS VACCINE BY COMPANY
3.1 Global Enterovirus Vaccine Breakdown Data by Company
3.1.1 Global Enterovirus Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Enterovirus Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Enterovirus Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Enterovirus Vaccine Revenue by Company (2018-2023)
3.2.2 Global Enterovirus Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Enterovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Enterovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enterovirus Vaccine Product Location Distribution
3.4.2 Players Enterovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENTEROVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Enterovirus Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Enterovirus Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Enterovirus Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Enterovirus Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Enterovirus Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Enterovirus Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Enterovirus Vaccine Sales Growth
4.4 APAC Enterovirus Vaccine Sales Growth
4.5 Europe Enterovirus Vaccine Sales Growth
4.6 Middle East & Africa Enterovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Enterovirus Vaccine Sales by Country
5.1.1 Americas Enterovirus Vaccine Sales by Country (2018-2023)
5.1.2 Americas Enterovirus Vaccine Revenue by Country (2018-2023)
5.2 Americas Enterovirus Vaccine Sales by Type
5.3 Americas Enterovirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enterovirus Vaccine Sales by Region
6.1.1 APAC Enterovirus Vaccine Sales by Region (2018-2023)
6.1.2 APAC Enterovirus Vaccine Revenue by Region (2018-2023)
6.2 APAC Enterovirus Vaccine Sales by Type
6.3 APAC Enterovirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enterovirus Vaccine by Country
7.1.1 Europe Enterovirus Vaccine Sales by Country (2018-2023)
7.1.2 Europe Enterovirus Vaccine Revenue by Country (2018-2023)
7.2 Europe Enterovirus Vaccine Sales by Type
7.3 Europe Enterovirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enterovirus Vaccine by Country
8.1.1 Middle East & Africa Enterovirus Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Enterovirus Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Enterovirus Vaccine Sales by Type
8.3 Middle East & Africa Enterovirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enterovirus Vaccine
10.3 Manufacturing Process Analysis of Enterovirus Vaccine
10.4 Industry Chain Structure of Enterovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enterovirus Vaccine Distributors
11.3 Enterovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR ENTEROVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Enterovirus Vaccine Market Size Forecast by Region
12.1.1 Global Enterovirus Vaccine Forecast by Region (2024-2029)
12.1.2 Global Enterovirus Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enterovirus Vaccine Forecast by Type
12.7 Global Enterovirus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sinovac Biotech
13.1.1 Sinovac Biotech Company Information
13.1.2 Sinovac Biotech Enterovirus Vaccine Product Portfolios and Specifications
13.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sinovac Biotech Main Business Overview
13.1.5 Sinovac Biotech Latest Developments
13.2 Medigen Vaccine Biologics
13.2.1 Medigen Vaccine Biologics Company Information
13.2.2 Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolios and Specifications
13.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medigen Vaccine Biologics Main Business Overview
13.2.5 Medigen Vaccine Biologics Latest Developments
13.3 Shenzhen Neptunus
13.3.1 Shenzhen Neptunus Company Information
13.3.2 Shenzhen Neptunus Enterovirus Vaccine Product Portfolios and Specifications
13.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shenzhen Neptunus Main Business Overview
13.3.5 Shenzhen Neptunus Latest Developments
13.4 Sinopharm
13.4.1 Sinopharm Company Information
13.4.2 Sinopharm Enterovirus Vaccine Product Portfolios and Specifications
13.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinopharm Main Business Overview
13.4.5 Sinopharm Latest Developments
13.5 Adimmune
13.5.1 Adimmune Company Information
13.5.2 Adimmune Enterovirus Vaccine Product Portfolios and Specifications
13.5.3 Adimmune Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Adimmune Main Business Overview
13.5.5 Adimmune Latest Developments
13.6 Intravacc
13.6.1 Intravacc Company Information
13.6.2 Intravacc Enterovirus Vaccine Product Portfolios and Specifications
13.6.3 Intravacc Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Intravacc Main Business Overview
13.6.5 Intravacc Latest Developments
13.7 Shanghai Zerun Biotechnology
13.7.1 Shanghai Zerun Biotechnology Company Information
13.7.2 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
13.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shanghai Zerun Biotechnology Main Business Overview
13.7.5 Shanghai Zerun Biotechnology Latest Developments
13.8 Beijing Minhai Biotechnology
13.8.1 Beijing Minhai Biotechnology Company Information
13.8.2 Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
13.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Minhai Biotechnology Main Business Overview
13.8.5 Beijing Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enterovirus Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Enterovirus Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Coxasckievirus A
Table 4. Major Players of Coxasckievirus B
Table 5. Major Players of Human Enterovirus 71
Table 6. Major Players of Others
Table 7. Global Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 8. Global Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Enterovirus Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Enterovirus Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 13. Global Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Enterovirus Vaccine Revenue by Application (2018-2023)
Table 15. Global Enterovirus Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Enterovirus Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Enterovirus Vaccine Sales by Company (2018-2023) & (K Doses)
Table 18. Global Enterovirus Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Enterovirus Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Enterovirus Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Enterovirus Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Enterovirus Vaccine Producing Area Distribution and Sales Area
Table 23. Players Enterovirus Vaccine Products Offered
Table 24. Enterovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Enterovirus Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Enterovirus Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Enterovirus Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Enterovirus Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Enterovirus Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Enterovirus Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Enterovirus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Enterovirus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Enterovirus Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Enterovirus Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Enterovirus Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Enterovirus Vaccine
Table 60. Key Market Challenges & Risks of Enterovirus Vaccine
Table 61. Key Industry Trends of Enterovirus Vaccine
Table 62. Enterovirus Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Enterovirus Vaccine Distributors List
Table 65. Enterovirus Vaccine Customer List
Table 66. Global Enterovirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Enterovirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Enterovirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Enterovirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Enterovirus Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Enterovirus Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Enterovirus Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Enterovirus Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sinovac Biotech Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sinovac Biotech Enterovirus Vaccine Product Portfolios and Specifications
Table 82. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Sinovac Biotech Main Business
Table 84. Sinovac Biotech Latest Developments
Table 85. Medigen Vaccine Biologics Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolios and Specifications
Table 87. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Medigen Vaccine Biologics Main Business
Table 89. Medigen Vaccine Biologics Latest Developments
Table 90. Shenzhen Neptunus Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Shenzhen Neptunus Enterovirus Vaccine Product Portfolios and Specifications
Table 92. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Shenzhen Neptunus Main Business
Table 94. Shenzhen Neptunus Latest Developments
Table 95. Sinopharm Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Sinopharm Enterovirus Vaccine Product Portfolios and Specifications
Table 97. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Sinopharm Main Business
Table 99. Sinopharm Latest Developments
Table 100. Adimmune Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Adimmune Enterovirus Vaccine Product Portfolios and Specifications
Table 102. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Adimmune Main Business
Table 104. Adimmune Latest Developments
Table 105. Intravacc Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Intravacc Enterovirus Vaccine Product Portfolios and Specifications
Table 107. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Intravacc Main Business
Table 109. Intravacc Latest Developments
Table 110. Shanghai Zerun Biotechnology Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
Table 112. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. Shanghai Zerun Biotechnology Main Business
Table 114. Shanghai Zerun Biotechnology Latest Developments
Table 115. Beijing Minhai Biotechnology Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
Table 117. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Beijing Minhai Biotechnology Main Business
Table 119. Beijing Minhai Biotechnology Latest Developments
Table 1. Enterovirus Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Enterovirus Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Coxasckievirus A
Table 4. Major Players of Coxasckievirus B
Table 5. Major Players of Human Enterovirus 71
Table 6. Major Players of Others
Table 7. Global Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 8. Global Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Enterovirus Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Enterovirus Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 13. Global Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Enterovirus Vaccine Revenue by Application (2018-2023)
Table 15. Global Enterovirus Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Enterovirus Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Enterovirus Vaccine Sales by Company (2018-2023) & (K Doses)
Table 18. Global Enterovirus Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Enterovirus Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Enterovirus Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Enterovirus Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Enterovirus Vaccine Producing Area Distribution and Sales Area
Table 23. Players Enterovirus Vaccine Products Offered
Table 24. Enterovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Enterovirus Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Enterovirus Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Enterovirus Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Enterovirus Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Enterovirus Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Enterovirus Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Enterovirus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Enterovirus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Enterovirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Enterovirus Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Enterovirus Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Enterovirus Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Enterovirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Enterovirus Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Enterovirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Enterovirus Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Enterovirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Enterovirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Enterovirus Vaccine
Table 60. Key Market Challenges & Risks of Enterovirus Vaccine
Table 61. Key Industry Trends of Enterovirus Vaccine
Table 62. Enterovirus Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Enterovirus Vaccine Distributors List
Table 65. Enterovirus Vaccine Customer List
Table 66. Global Enterovirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Enterovirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Enterovirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Enterovirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Enterovirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Enterovirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Enterovirus Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Enterovirus Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Enterovirus Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Enterovirus Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sinovac Biotech Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sinovac Biotech Enterovirus Vaccine Product Portfolios and Specifications
Table 82. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Sinovac Biotech Main Business
Table 84. Sinovac Biotech Latest Developments
Table 85. Medigen Vaccine Biologics Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolios and Specifications
Table 87. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Medigen Vaccine Biologics Main Business
Table 89. Medigen Vaccine Biologics Latest Developments
Table 90. Shenzhen Neptunus Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Shenzhen Neptunus Enterovirus Vaccine Product Portfolios and Specifications
Table 92. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Shenzhen Neptunus Main Business
Table 94. Shenzhen Neptunus Latest Developments
Table 95. Sinopharm Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Sinopharm Enterovirus Vaccine Product Portfolios and Specifications
Table 97. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Sinopharm Main Business
Table 99. Sinopharm Latest Developments
Table 100. Adimmune Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Adimmune Enterovirus Vaccine Product Portfolios and Specifications
Table 102. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Adimmune Main Business
Table 104. Adimmune Latest Developments
Table 105. Intravacc Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Intravacc Enterovirus Vaccine Product Portfolios and Specifications
Table 107. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Intravacc Main Business
Table 109. Intravacc Latest Developments
Table 110. Shanghai Zerun Biotechnology Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
Table 112. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. Shanghai Zerun Biotechnology Main Business
Table 114. Shanghai Zerun Biotechnology Latest Developments
Table 115. Beijing Minhai Biotechnology Basic Information, Enterovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolios and Specifications
Table 117. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Beijing Minhai Biotechnology Main Business
Table 119. Beijing Minhai Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Enterovirus Vaccine
Figure 2. Enterovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enterovirus Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Enterovirus Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Enterovirus Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Coxasckievirus A
Figure 10. Product Picture of Coxasckievirus B
Figure 11. Product Picture of Human Enterovirus 71
Figure 12. Product Picture of Others
Figure 13. Global Enterovirus Vaccine Sales Market Share by Type in 2022
Figure 14. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Enterovirus Vaccine Consumed in Hospital
Figure 16. Global Enterovirus Vaccine Market: Hospital (2018-2023) & (K Doses)
Figure 17. Enterovirus Vaccine Consumed in Research Institute
Figure 18. Global Enterovirus Vaccine Market: Research Institute (2018-2023) & (K Doses)
Figure 19. Enterovirus Vaccine Consumed in Others
Figure 20. Global Enterovirus Vaccine Market: Others (2018-2023) & (K Doses)
Figure 21. Global Enterovirus Vaccine Sales Market Share by Application (2022)
Figure 22. Global Enterovirus Vaccine Revenue Market Share by Application in 2022
Figure 23. Enterovirus Vaccine Sales Market by Company in 2022 (K Doses)
Figure 24. Global Enterovirus Vaccine Sales Market Share by Company in 2022
Figure 25. Enterovirus Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Enterovirus Vaccine Revenue Market Share by Company in 2022
Figure 27. Global Enterovirus Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Enterovirus Vaccine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 30. Americas Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 32. APAC Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 34. Europe Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 38. Americas Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 39. Americas Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 40. Americas Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 41. United States Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Enterovirus Vaccine Sales Market Share by Region in 2022
Figure 46. APAC Enterovirus Vaccine Revenue Market Share by Regions in 2022
Figure 47. APAC Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 48. APAC Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 49. China Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 57. Europe Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 58. Europe Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 59. Europe Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 60. Germany Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Enterovirus Vaccine in 2022
Figure 75. Manufacturing Process Analysis of Enterovirus Vaccine
Figure 76. Industry Chain Structure of Enterovirus Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Enterovirus Vaccine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Enterovirus Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Enterovirus Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Enterovirus Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Enterovirus Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Enterovirus Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Enterovirus Vaccine
Figure 2. Enterovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enterovirus Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Enterovirus Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Enterovirus Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Coxasckievirus A
Figure 10. Product Picture of Coxasckievirus B
Figure 11. Product Picture of Human Enterovirus 71
Figure 12. Product Picture of Others
Figure 13. Global Enterovirus Vaccine Sales Market Share by Type in 2022
Figure 14. Global Enterovirus Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Enterovirus Vaccine Consumed in Hospital
Figure 16. Global Enterovirus Vaccine Market: Hospital (2018-2023) & (K Doses)
Figure 17. Enterovirus Vaccine Consumed in Research Institute
Figure 18. Global Enterovirus Vaccine Market: Research Institute (2018-2023) & (K Doses)
Figure 19. Enterovirus Vaccine Consumed in Others
Figure 20. Global Enterovirus Vaccine Market: Others (2018-2023) & (K Doses)
Figure 21. Global Enterovirus Vaccine Sales Market Share by Application (2022)
Figure 22. Global Enterovirus Vaccine Revenue Market Share by Application in 2022
Figure 23. Enterovirus Vaccine Sales Market by Company in 2022 (K Doses)
Figure 24. Global Enterovirus Vaccine Sales Market Share by Company in 2022
Figure 25. Enterovirus Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Enterovirus Vaccine Revenue Market Share by Company in 2022
Figure 27. Global Enterovirus Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Enterovirus Vaccine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 30. Americas Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 32. APAC Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 34. Europe Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Enterovirus Vaccine Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Enterovirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 38. Americas Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 39. Americas Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 40. Americas Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 41. United States Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Enterovirus Vaccine Sales Market Share by Region in 2022
Figure 46. APAC Enterovirus Vaccine Revenue Market Share by Regions in 2022
Figure 47. APAC Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 48. APAC Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 49. China Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 57. Europe Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 58. Europe Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 59. Europe Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 60. Germany Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Enterovirus Vaccine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Enterovirus Vaccine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Enterovirus Vaccine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Enterovirus Vaccine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Enterovirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Enterovirus Vaccine in 2022
Figure 75. Manufacturing Process Analysis of Enterovirus Vaccine
Figure 76. Industry Chain Structure of Enterovirus Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Enterovirus Vaccine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Enterovirus Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Enterovirus Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Enterovirus Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Enterovirus Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Enterovirus Vaccine Revenue Market Share Forecast by Application (2024-2029)
